XML 88 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBORDINATED DEBENTURES
12 Months Ended
Dec. 31, 2012
SUBORDINATED DEBENTURES [Abstract]  
SUBORDINATED DEBENTURES
NOTE K—SUBORDINATED DEBENTURES
 
Subordinated debt (included in liabilities subject to compromise at December 31, 2012, see Note C) relates to trust-preferred securities issued by Capitol which are summarized as follows at December 31 (in $1,000s):

 
Current
Interest Rate
 
Scheduled
Maturity
 
Aggregate
Liquidation
Amount
  
Net Carrying Amount
 
   
2012
  
2011
 
 
 
 
 
  
  
 
Capitol Trust I
  8.50% fixed
2027
 
$
13,494
  
$
13,494
  
$
13,186
 
Capitol Trust II
10.25% fixed
2031
  
10,000
   
10,000
   
9,803
 
Capitol Statutory Trust III
  3.89% variable
2031
  
15,000
   
15,000
   
14,706
 
Capitol Bancorp Capital Trust IV
  3.99% variable
2032
  
3,000
   
3,000
   
2,931
 
Capitol Trust VI
  3.63% variable
2033
  
10,000
   
10,000
   
9,787
 
Capitol Trust VII
  7.78% fixed
2033
  
10,000
   
10,000
   
9,891
 
Capitol Statutory Trust VIII
  3.26% variable
2033
  
20,000
   
20,000
   
19,715
 
Capitol Trust IX
  7.69% fixed
2034
  
10,000
   
10,000
   
9,952
 
Capitol Bancorp Trust X
  1.98% variable
2037
  
33,000
   
33,000
   
33,000
 
Capitol Trust XI
  1.96% variable
2037
  
20,000
   
20,000
   
20,000
 
Capitol Trust XII
10.50% fixed
2038
  
6,802
   
6,802
   
6,185
 
 
 
 
            
 
 
   
 
$
151,296
  
$
151,296
  
$
149,156
 

Securities of Capitol Trust I and XII were issued in public offerings in 1997 and 2008, respectively.  All other securities were formed in conjunction with private placements of trust-preferred securities.  Each of these securities has similar terms and, subject to certain provisions, may be called by Capitol five years after issuance.  The liquidation amount of these securities is guaranteed by Capitol.

On January 31, 2011, Capitol accepted for exchange 1,180,602 of the 2,530,000 outstanding shares of trust-preferred securities of Capitol Trust I and 773,934 of the 1,454,100 outstanding shares of trust-preferred securities of Capitol Trust XII and, pursuant to the related exchange offer, issued approximately 19.5 million previously-unissued shares of Capitol's common stock.  This exchange resulted in the retirement of approximately $19.5 million aggregate liquidation amount of the trust-preferred securities on a combined basis and eliminated approximately $3.4 million of accrued interest payable associated with the retired securities, which collectively increased Capitol's equity and regulatory capital by $21.9 million, including a gain on the transaction of approximately $16.9 million.

In 2009, the Corporation commenced the deferral of interest payments on its various trust-preferred securities, as is permitted under the terms of the securities, in order to conserve cash resources.  The payment of interest on those securities may be deferred for periods up to five years.  During such deferral periods, Capitol is prohibited from paying dividends on its common stock (subject to certain exceptions) and is further restricted by Capitol's written agreement with the Federal Reserve Bank of Chicago, which prohibits both payment of interest on the trust-preferred securities and cash dividends without prior written approval from
 
 
that agency.  Upon termination of a deferral-period, all prior accrued and unpaid interest becomes immediately due and payable to holders of the securities at that time.  Accrued interest payable on such securities approximated $33.3 million and $27.6 million at December 31, 2012 and 2011, respectively.  Holders of the trust-preferred securities recognize current taxable income relating to the deferred interest payments.  The accrual of interest was discontinued as of the bankruptcy filing date (see Note C).
 
Documents governing the trusts give holders of the securities preference on liquidation over the holders of Capitol's common stock.  When the trust-preferred securities were issued, they were treated as qualifying regulatory capital.  Under current regulatory guidelines, none of Capitol's trust-preferred securities are included as qualifying regulatory capital as of December 31, 2012 and 2011.